Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px
Document › Details

Agilent Technologies Inc.. (10/26/12). "Press Release: Agilent Technologies’ and Premier Biosoft’s Platforms Work Together to Advance Lipidomics Research. Complementary Tools Eliminate Bottlenecks in Data Processing and Analysis". Santa Clara, CA & Palo

Organisation Organisation Premier Biosoft International
  Group Premier Biosoft (Group)
Products Product Pathway Architect s/w (module of GeneSpring)
  Product 2 SimLipid lipid identification software tool
Index term Index term Agilent–Premier Biosoft: SimLipid s/w, 201210– collab integration SimLipid 3.3 + Agilent MS Systems + Pathway Architect s/w for lipidomics research
Persons Person Kassel, Daniel B. (Agilent 201210 Senior Director LC/MS Global Marketing)
  Person 2 Apte, Arun (Premier Biosoft 201210 CEO)
     


Agilent Technologies Inc. (NYSE: A) and PREMIER Biosoft today announced that they will each support the combined use of their respective technologies to help clinical researchers advance lipidomics research. By integrating complementary technologies, researchers can seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease.

The power of Agilent's industry-leading time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software combined with Premier Biosoft's SimLipid 3.3 identification and quantification software enables researchers to overcome many of the obstacles inherent in lipid identification and analysis. This will give them a distinct advantage in their efforts to map the lipid pathways associated with metabolic disease.

"Just as challenging as mapping and sequencing the human genome is identifying and sequencing the thousands of lipid species involved in human metabolism," said Dr. Daniel B. Kassel, Agilent's senior director of LC/MS global marketing. "By utilizing this combined network of technologies, researchers can be confident in the analytical strength they have come to expect from Agilent and from the advanced lipid identification capabilities provided in PREMIER Biosoft's SimLipid software."

"By connecting these complementary technologies, researchers can maximize the analytical capabilities of Agilent's high-end MS instrumentation and software with our high-throughput MS and MS/MS data analysis tools," said Arun Apte, chief executive officer at PREMIER Biosoft. "Our SimLipid software supports data from Agilent's well-known MassHunter, Mass Profiler Professional and Pathway Architect software programs, creating an integrated workflow for the accurate and efficient identification and contextualization of lipids on metabolic pathways."

Information on SimLipid 3.3 is available at www.premierbiosoft.com/lipid/index.html.

Information on Agilent's Mass Profiler Professional Software is available at www.chem.agilent.com/en-US/products-services/Software-Informatics/Mass-Profiler-Professional-Software/Pages/default.aspx


About PREMIER Biosoft

PREMIER Biosoft (www.premierbiosoft.com) was founded in 1994. The company is led by computer scientists, statisticians and biologists dedicated to producing cutting-edge intuitive software for research in life sciences. The company's goal is to study the most recent innovations in life sciences and translate them into software products to aid research. Follow PREMIER Biosoft on Twitter @PREMIERBiosoft and on Facebook.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,000 employees serve customers in more than 100 countries. Agilent had net revenues of $6.6 billion in fiscal 2011. Information about Agilent is available at www.agilent.com.

# # #

EDITORIAL CONTACTS: PRCA12064

Susan Berg, Agilent
+1 408 553 7093
susan_berg1@agilent.com

Shonali Paul, PREMIER Biosoft
+1 650 856 2703
shonali@premierbiosoft.com

NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.

Selina Muthada-Pottayya
Assistant Account Executive
dna medical communications
Tel: +44 (0)20 7067 0489
Fax: +44 (0)20 7067 0076
Email:spottayya@dnamedcomms.co.uk
Wedsite: www.dnamedcomms.co.uk

2 Waterhouse Square, 140 Holborn, London, EC1N 2AE

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px

More documents for Agilent (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px